Methods of using immunoglobulin (Ig) compositions

Abstract

The invention is directed to methods of using Ig compositions to prevent and/or treat humans, livestock and/or domesticated animals suffering from a variety of disorders. The Ig composition comprises a concentrated amount of one or more immunoglobulins selected from the group consisting of alpha, beta, and gamma globulins. Preferably, the Ig composition comprises other antibodies identified as providing an immune response and/or immune factors such as complement. The Ig composition preferably includes immunoglobulins specific to a variety of antigens.

Description

[0001] This application is a Continuation of U.S. patent application Ser. No. 09 / 586,510, filed Jun. 2, 2002, which is a Continuation of U.S. patent application Ser. No. 08 / 685,052, filed Jul. 23, 1996, now abandoned, which is a Continuation-in-Part of U.S. patent application Ser. No. 08 / 349,010, filed Dec. 2, 1994, which is now issued as U.S. Pat. No. 5,548,066, all of which are hereby incorporated herein by reference.[0002] Not applicable.[0003] 1. Field of the Invention[0004] The present invention is generally directed to immunoglobulin (Ig) compositions and methods of therapeutically using Ig compositions in animals including humans, livestock and domesticated animals. Several embodiments of the invention are directed to unique and novel methods of using Ig compositions in the treatment of certain maladies or conditions. These methods include the use of an Ig composition for treating stress induced respiratory disorders, diarrhea such as diarrhea caused by Parvovirus in canines,...

AI Technical Summary

Problems solved by technology

Furthermore, it is believed that white blood cells may become trapped within the red blood cells during the clotting process such that a portion of these cells remain intact and do not expel transfer factors into the serum.